Merck Bolsters Oncology Pipeline with $2.13 Billion SciBrunch Licensing Deal for KRAS G12D Inhibitor
In a significant move to reshape its oncology portfolio ahead of impending patent cliffs, Merck & Co. has secured exclusive...
merck
Merck KGaA Unveils $11.3 Billion Acquisition of Bio-Techne to Reshape Life Sciences Landscape
In a landmark move that promises to redraw the boundaries of the global life sciences sector, Merck KGaA, Darmstadt, Germany,...
Merck and Protillion Biosciences Forge $510M AI-Driven Drug Discovery Partnership
In a significant move to reshape the future of biologics, pharmaceutical giant Merck & Co. has entered into a multi-target...
